These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15521328

  • 1. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S, El Massik MA, Abdallah OY, Daabis NA.
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [Abstract] [Full Text] [Related]

  • 2. Design and in vitro evaluation of a novel vaginal drug delivery system based on gelucire.
    Geeta MP, Madhabhai MP.
    Curr Drug Deliv; 2009 Apr; 6(2):159-65. PubMed ID: 19450222
    [Abstract] [Full Text] [Related]

  • 3. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 4. Suitability of Gelucire 50/13 for controlled release formulation of salbutamol sulphate.
    Mohsin S, Rahman NU, Idrees MA, Sarfraz MK, Khan MK, Mustafa G.
    Pak J Pharm Sci; 2012 Jan; 25(1):35-41. PubMed ID: 22186307
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of the mechanisms of drug release from glyceride bases.
    Sutananta W, Craig DQ, Newton JM.
    J Pharm Pharmacol; 1995 Mar; 47(3):182-7. PubMed ID: 7602477
    [Abstract] [Full Text] [Related]

  • 6. Effect of aging on the release of salbutamol sulfate from lipid matrices.
    San Vicente A, Hernández RM, Gascón AR, Calvo MB, Pedraz JL.
    Int J Pharm; 2000 Nov 04; 208(1-2):13-21. PubMed ID: 11064207
    [Abstract] [Full Text] [Related]

  • 7. Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules.
    Ratsimbazafy V, Bourret E, Duclos R, Brossard C.
    Eur J Pharm Biopharm; 1999 Nov 04; 48(3):247-52. PubMed ID: 10612036
    [Abstract] [Full Text] [Related]

  • 8. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation.
    El Massik MA, Abdallah OY, Galal S, Daabis NA.
    Drug Dev Ind Pharm; 2003 May 04; 29(5):531-43. PubMed ID: 12779283
    [Abstract] [Full Text] [Related]

  • 9. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases.
    Sutananta W, Craig DQ, Newton JM.
    J Pharm Pharmacol; 1995 May 04; 47(5):355-9. PubMed ID: 7494182
    [Abstract] [Full Text] [Related]

  • 10. Significance of lipid matrix aging on in vitro release and in vivo bioavailability.
    Choy YW, Khan N, Yuen KH.
    Int J Pharm; 2005 Aug 11; 299(1-2):55-64. PubMed ID: 15955645
    [Abstract] [Full Text] [Related]

  • 11. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B, Tadikonda RR, Vemula SK.
    Drug Dev Ind Pharm; 2015 Aug 11; 41(8):1254-62. PubMed ID: 25039470
    [Abstract] [Full Text] [Related]

  • 12. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A.
    Int J Pharm; 2007 Aug 16; 341(1-2):26-34. PubMed ID: 17498898
    [Abstract] [Full Text] [Related]

  • 13. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S, Patra ChN, Swain S, Panigrahi KC, Nayak S, Dinda SC, Rao ME.
    Drug Deliv; 2015 Jan 16; 22(1):125-35. PubMed ID: 24417642
    [Abstract] [Full Text] [Related]

  • 14. Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.
    da Fonseca Antunes AB, De Geest BG, Vervaet C, Remon JP.
    Drug Dev Ind Pharm; 2013 May 16; 39(5):791-8. PubMed ID: 22871141
    [Abstract] [Full Text] [Related]

  • 15. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
    Laukamp EJ, Vynckier AK, Voorspoels J, Thommes M, Breitkreutz J.
    Eur J Pharm Biopharm; 2015 Jan 16; 89():357-64. PubMed ID: 25555454
    [Abstract] [Full Text] [Related]

  • 16. Smart phase transformation system based on lyotropic liquid crystalline@hard capsules for sustained release of hydrophilic and hydrophobic drugs.
    Zhang X, Xiao Y, Huang Z, Chen J, Cui Y, Niu B, Huang Y, Pan X, Wu C.
    Drug Deliv; 2020 Dec 16; 27(1):449-459. PubMed ID: 32157918
    [Abstract] [Full Text] [Related]

  • 17. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS, Biradar SV, Aher S, Paradkar AR.
    J Pharm Pharmacol; 2009 Jun 16; 61(6):743-51. PubMed ID: 19505364
    [Abstract] [Full Text] [Related]

  • 18. Effect of formulation on the rheology of theophylline compound suspensions in Gelucires.
    Ratsimbazafy V, Bourret E, Brossard C.
    J Pharm Pharmacol; 1997 Sep 16; 49(9):852-7. PubMed ID: 9306251
    [Abstract] [Full Text] [Related]

  • 19. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
    Vasvári G, Csontos B, Sovány T, Regdon G, Bényei A, Váradi J, Bácskay I, Ujhelyi Z, Fehér P, Sinka D, Nguyen TLP, Vecsernyés M, Fenyvesi F.
    AAPS PharmSciTech; 2018 Oct 16; 19(7):3165-3176. PubMed ID: 30136176
    [Abstract] [Full Text] [Related]

  • 20. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
    Turner S, Federici C, Hite M, Fassihi R.
    Drug Dev Ind Pharm; 2004 Sep 16; 30(8):797-807. PubMed ID: 15521326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.